艾滋病与幽门螺杆菌感染关系的研究进展
Research Progress on the Relationship between HIV/AIDS and Helicobacter pylori Infection
DOI: 10.12677/acm.2024.1451544, PDF,   
作者: 谢玉娟：广州医科大学研究生院，广东 广州；詹远京*：广州医科大学附属市八医院消化内科，广东 广州
关键词: 幽门螺杆菌；艾滋病；CD4 T细胞；免疫功能；根除治疗；Helicobacter pylori； HIV/AIDS； CD4 Tlymphocyte； Immunity； Eradication Therapy
摘要: 幽门螺杆菌和艾滋病都是全球性公共卫生问题，多年以来一直有研究关注两者相互感染的关系。多项研究的数据显示出幽门螺杆菌的发病率与艾滋病毒之间存在负相关，特别是在CD4 T淋巴细胞计数低于200 cells/μl阈值的患者，部分研究发现这类特殊人群的幽门螺杆菌根除效果似乎要比普通人群差。该综述主要从艾滋病毒合并幽门螺杆菌感染的流行情况、危险因素、治疗等方面进行描述。
Abstract: HIV/AIDS and Helicobacter pylori infections remain major global public health problems, many studies focus their attention on the relationship between HIV/AIDS and Helicobacter pylori. Several studies have detected a lower prevalence of H. pylori in patients with HIV infection, especially in patients with CD4 Tlymphocyte count below 200 cells/μl. Moreover, some studies have found that the eradication effect of Helicobacter pylori in this special population seems to be worse than that in the general population. This review describes the prevalence, risk factors and treatment of HIV complicated with Helicobacter pylori infection.
文章引用：谢玉娟, 詹远京. 艾滋病与幽门螺杆菌感染关系的研究进展[J]. 临床医学进展, 2024, 14(5): 1223-1229. https://doi.org/10.12677/acm.2024.1451544

参考文献

[1] Diaconu, S., Predescu, A., Moldoveanu, A., Pop, C.S. and Fierbințeanu-Braticevici, C. (2017) Helicobacter pylori Infection: Old and New. Journal of Medicine and Life, 10, 112-117.
[2] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 61, 1-241.
[3] Ohata, H., Kitauchi, S., Yoshimura, N., Mugitani, K., Iwane, M., Nakamura, H., Yoshikawa, A., Yanaoka, K., Arii, K., Tamai, H., Shimizu, Y., Takeshita, T., Mohara, O. and Ichinose, M. (2004) Progression of Chronic Atrophic Gastritis Associated with Helicobacter pylori Infection Increases Risk of Gastric Cancer. International Journal of Cancer, 109, 138-143. [Google Scholar] [CrossRef] [PubMed]
[4] He, S. and Wu, Y. (2019) Relationships between HIV-Mediated Chemokine Coreceptor Signaling, Cofilin Hyperactivation, Viral Tropism Switch and HIV-Mediated CD4 Depletion. Current HIV Research, 17, 388-396. [Google Scholar] [CrossRef] 
[5] 李莉, 曹韵贞. 几种免疫细胞在感染HIV-1过程中的作用[J]. 中国艾滋病性病, 2007(1): 82-86.
[6] 中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版) [J]. 协和医学杂志, 2022, 13(2): 203-226.
[7] Nkuize, M., De Wit, S., Demetter, P., Eisendrath, P. and Vanderpas, J. (2023) Helicobacter pylori and Human Immunodeficiency Virus Co-Infection: Potential Implications for Future Gastric Cancer Risk. Microorganisms, 11, Article No. 887. [Google Scholar] [CrossRef] [PubMed]
[8] Mach, T., Skwara, P., Biesiada, G., Cieśla, A. and Macura, A. (2007) Morphological Changes of the Upper Gastrointestinal Tract Mucosa and Helicobacter pylori Infection in HIV-Positive Patients with Severe Immunodeficiency and Symptoms of Dyspepsia. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 13, CR14-CR19.
[9] Chiu, H.M., Wu, M.S., Hung, C.C., Shun, C.T. and Lin, J.T. (2004) Low Prevalence of Helicobacter pylori but High Prevalence of Cytomegalovirus-Associated Peptic Ulcer Disease in AIDS Patients: Comparative Study of Symptomatic Subjects Evaluated By Endoscopy and CD4 Counts. Journal of Gastroenterology and Hepatology, 19, 423-428. [Google Scholar] [CrossRef] [PubMed]
[10] Lichterfeld, M., Lorenz, C., Nischalke, H.D., Scheurlen, C., Sauerbruch, T. and Rockstroh, J.K. (2002) Decreased Prevalence of Helicobacter pylori Infection in HIV Patients with AIDS Defining Diseases. Zeitschrift Fur Gastroenterologie, 40, 11-14. [Google Scholar] [CrossRef] [PubMed]
[11] Nevin, D.T., Morgan, C.J., Graham, D.Y. and Genta, R.M. (2014) Helicobacter pylori Gastritis in HIV-Infected Patients: A Review. Helicobacter, 19, 323-329. [Google Scholar] [CrossRef] [PubMed]
[12] Sarfo, F.S., Eberhardt, K.A., Dompreh, A., Kuffour, E.O., Soltau, M., Schachscheider, M., Drexler, J.F., Eis-Hübinger, A.M., Häussinger, D., Oteng-Seifah, E.E., Bedu-Addo, G., Phillips, R.O., Norman, B., Burchard, G. and Feldt, T. (2015) Helicobacter pylori Infection Is Associated with Higher CD4 T Cell Counts and Lower HIV-1 Viral Loads in ART-Naïve HIV-Positive Patients in Ghana. PLOS ONE, 10, e0143388. [Google Scholar] [CrossRef] [PubMed]
[13] Fialho, A.B., Braga-Neto, M.B., Guerra, E.J., Fialho, A.M., Fernandes, K.C., Sun, J.L., Takeda, C.F., Silva, C.I., Queiroz, D.M. and Braga, L.L. (2011) Low Prevalence of H. pylori Infection in HIV-Positive Patients in the Northeast of Brazil. BMC Gastroenterology, 11, Article No. 13. [Google Scholar] [CrossRef] 
[14] Panos, G.Z., Xirouchakis, E., Tzias, V., Charatsis, G., Bliziotis, I.A., Doulgeroglou, V., Margetis, N. and Falagas, M.E. (2007) Helicobacter pylori Infection in Symptomatic HIV-Seropositive and-Seronegative Patients: A Case-Control Study. AIDS Research and Human Retroviruses, 23, 709-712. [Google Scholar] [CrossRef] [PubMed]
[15] Hestvik, E., Tylleskar, T., Ndeezi, G., Grahnquist, L., Olafsdottir, E., Tumwine, J.K. and Kaddu-Mulindwa, D.H. (2011) Prevalence of Helicobacter pylori in HIV-Infected, HAART-Naïve Ugandan Children: A Hospital-Based Survey. Journal of the International AIDS Society, 14, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[16] Abdollahi, A., Shoar, S., Jafari, S. and Emadi-Kochak, H. (2014) Seroprevalence of Helicobacter pylori in Human Immunodeficiency Virus-Positive Patients and It’s Correlation with CD4( ) Lymphocyte Count. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 55, 67-72. [Google Scholar] [CrossRef] [PubMed]
[17] 许柯, 赵文, 王同单. AIDS患者13C-尿素呼气试验幽门螺杆菌检测结果分析[J]. 河南预防医学杂志, 2019, 30(4): 291-293.
[18] 刘放. 75例HIV/AIDS14C-尿素呼气试验幽门螺杆菌检测结果分析[J]. 中国医药导刊, 2009, 11(10): 1798-1799.
[19] 程计林, 黄绍萍, 须亚红, 等. AIDS与肝病患者胃镜活检组织幽门螺杆菌感染和消化性溃疡发现率的临床比较研究[J]. 胃肠病学和肝病学杂志, 2011, 20(9): 847-849.
[20] 白雪, 须亚红, 艾迎春, 等. 艾滋病与肝病患者胃窦黏膜活检快速尿素酶检测幽门螺杆菌与病理学染色的比较研究[J]. 胃肠病学和肝病学杂志, 2014, 23(9): 1004-1007.
[21] Radovanović Spurnić, A., Brmbolić, B., Stojšić, Z., Pekmezović, T., Bukumirić, Z., Korać, M., Salemović, D., Pešić-Pavlović, I., Stevanović, G., Milošević, I. and Jevtović, D. (2017) The Increasing Prevalence of HIV/Helicobacter pylori Co-Infection over Time, along with the Evolution of Antiretroviral Therapy (ART). PeerJ, 5, e3392. [Google Scholar] [CrossRef] [PubMed]
[22] Romanelli, F., Smith, K.M. and Murphy, B.S. (2007) Does HIV Infection Alter the Incidence or Pathology of Helicobacter pylori Infection? AIDS Patient Care and STDs, 21, 908-919. [Google Scholar] [CrossRef] [PubMed]
[23] 吕富靖, 罗晓岚, 金瑞, 等. HIV/AIDS者胃幽门螺杆菌感染相关因素分析[J]. 中华消化内镜杂志, 2005, 22(4): 240-243.
[24] Skwara, P., Mach, T., Tomaszewska, R., Sobczyk-Krupiarz, I. and Cieśla, A. (2005) Studies on Relationship between Immunodeficiency in HIV-Infected People and Condition of Upper Gastrointestinal Tract Mucosa, Prevalence of Mycosis and Helicobacter pylori Infection. Przegladlekarski, 62, 1401-1404.
[25] Olmos, M., Araya, V., Pskorz, E., Quesada, E.C., Concetti, H., Perez, H. and Cahn, P. (2004) Coinfection: Helicobacter pylori/Human Immunodeficiency Virus. Digestive Diseases and Sciences, 49, 1836-1839. [Google Scholar] [CrossRef] [PubMed]
[26] Andoulo, F.A., Kowo, M., Ngatcha, G., Ndam, A.N., Awouoyiegnigni, B., Sida, M.B., Tzeuton, C. and Ndjitoyap Ndam, E.C. (2016) Prevalence of Helicobacter pylori Prevalence and Upper Gastrointestinal Endoscopy in HIV/AIDS Patients with Gastrointestinal Symptoms in the University Teaching Hospitals in Cameroon. Medecine et Santetropicales, 26, 278-282. [Google Scholar] [CrossRef] [PubMed]
[27] Spurnic, A.R., Bukumiric, Z., Jevtovic, D., Brmbolic, B., Pekmezovic, T., Salemovic, D., Pesic Pavlovic, I., Milosevic, I., Ranin, J. and Korac, M. (2021) Helicobacter pylori Infection Rates in Dyspeptic Serbian HIV-Infected Patients Compared to HIV-Negative Controls. PLOS ONE, 16, E0248041. [Google Scholar] [CrossRef] [PubMed]
[28] Cacciarelli, A.G., Marano, B.J., Gualtieri, N.M., Zuretti, A.R., Torres, R.A., Starpoli, A.A. and Robilotti, J.G. (1996) Lower Helicobacter pylori Infection and Peptic Ulcer Disease Prevalence in Patients with AIDS and Suppressed CD4 Counts. The American Journal of Gastroenterology, 91, 1783-1784.
[29] 苏东梅, 陈婉玲, 王伟峰, 等. HIV/AIDS患者幽门螺杆菌感染状况及影响因素分析[J]. 广西医学, 2018, 40(11): 1251-1253.
[30] 罗红彬, 胡中伟, 郭家伟. HIV/AIDS临床各期患者胃粘膜幽门螺杆菌感染研究[J]. 南方医科大学学报, 2009, 29(7): 1397-1399.
[31] Sato, H., Ota, Y., Kido, Y., Matsumoto, T., Matsubara, Y., Matano, T., Hirata, Y., Kawana-Tachikawa, A., Yamaoka, Y., Yotsuyanagi, H. and Adachi, E. (2020) Gut-Homing CD4 T Cells Are Associated with the Activity of Gastritis in HIV-Infected Adults. AIDS Research and Human Retroviruses, 36, 910-917. [Google Scholar] [CrossRef] [PubMed]
[32] Malaty, H.M., Kim, J.G., Kim, S.D. and Graham, D.Y. (1996) Prevalence of Helicobacter pylori Infection in Korean Children: Inverse Relation to Socioeconomic Status despite a Uniformly High Prevalence in Adults. American Journal of Epidemiology, 143, 257-262. [Google Scholar] [CrossRef] [PubMed]
[33] Lee, J.E., Lee, S.O., Sim, Y.K., Lee, S., Kim, G.H., Kang, J.S. and Lee, S.H. (2022) Seroprevalence of Helicobacter pylori in Human Immunodeficiency Virus-Infected Patients in a Tertiary Care Hospital in Busan, South Korea. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, 28, 1143-1147. [Google Scholar] [CrossRef] [PubMed]
[34] Nkuize, M., De Wit, S., Muls, V., Ntounda, R., Gomez-Galdon, M. and Buset, M. (2012) Comparison of Demographic Characteristics and Upper Gastrointestinal Endoscopy Findings in HIV-Positive, Antiretroviral-Treated Patients with and Without Helicobacter pylori Coinfection. Helicobacter, 17, 153-159. [Google Scholar] [CrossRef] [PubMed]
[35] Athmann, C., Zeng, N., Kang, T., Marcus, E.A., Scott, D.R., Rektorschek, M., Buhmann, A., Melchers, K. and Sachs, G. (2000) Local PH Elevation Mediated by the Intrabacterial Urease of Helicobacter pylori Cocultured with Gastric Cells. The Journal of Clinical Investigation, 106, 339-347. [Google Scholar] [CrossRef] 
[36] Malfertheiner, P., Camargo, M.C., El-Omar, E., Liou, J.M., Peek, R., Schulz, C., Smith, S.I. and Suerbaum, S. (2023) Helicobacter pylori Infection. Nature Reviews. Disease Primers, 9, 19. [Google Scholar] [CrossRef] [PubMed]
[37] Longo-Mbenza, B., Apalata, T., Longokolo, M., Mambimbi, M.M., Mokondjimobe, E., Gombet, T., Ellenga, B., Buassa-Bu-Tsumbu, B., Dipa, G.M., Luila, E.L. and NgeOkwe, A. (2015) Association of Helicobacter pylori Infection with the Metabolic Syndrome among HIV-Infected Black Africans Receiving Highly Active Antiretroviral Therapy. Cardiovascular Journal of Africa, 26, 52-56. [Google Scholar] [CrossRef] 
[38] Fabris, P., Pilotto, A., Bozzola, L., Tositti, G., Soffiati, G., Manfrin, V. and De Lalla, F. (2002) Serum Pepsinogen and Gastrin Levels in HIV-Positive Patients: Relationship with CD4 Cell Count and Helicobacter pylori Infection. Alimentary Pharmacology & Therapeutics, 16, 807-811. [Google Scholar] [CrossRef] [PubMed]
[39] 国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组, 等. 中国居民家庭幽门螺杆菌感染的防控和管理专家共识(2021年) [J]. 中华消化杂志, 2021, 41(4): 221-233.
[40] Marcus, E.A., Sachs, G. and Scott, D.R. (2015) Colloidal Bismuth Subcitrate Impedes Proton Entry into Helicobacter pylori and Increases the Efficacy of Growth-Dependent Antibiotics. Alimentary Pharmacology & Therapeutics, 42, 922-933. [Google Scholar] [CrossRef] [PubMed]
[41] Nyssen, O.P., Perez-Aisa, A., Castro-Fernandez, M., Pellicano, R., Huguet, J.M., Rodrigo, L., Ortuñ, J.O., Gomez-Rodriguez, B.J., Pinto, R.M., Areia, M., Perona, M., Nuñez, O., Romano, M., Gravina, A.G., Pozzati, L., Fernandez-Bermejo, M., Venerito, M., Malfertheiner, P., Fernanadez-Salazar, L. and Hp-EuReg Investigators (2021) European Registry on Helicobacter pylori Management: Single-Capsule Bismuth Quadruple Therapy Is Effective in Real-World Clinical Practice. United European Gastroenterology Journal, 9, 38-46. [Google Scholar] [CrossRef] [PubMed]
[42] Zagari, R.M., Romiti, A., Ierardi, E., Gravina, A.G., Panarese, A., Grande, G., Savarino, E., Maconi, G., Stasi, E., Eusebi, L.H., Farinati, F., Conigliaro, R., Bazzoli, F. and Romano, M. (2018) The “Three-in-One” Formulation of Bismuth Quadruple Therapy for Helicobacter pylori Eradication with or without Probiotics Supplementation: Efficacy and Safety in Daily Clinical Practice. Helicobacter, 23, E12502. [Google Scholar] [CrossRef] [PubMed]
[43] Mesfun, M.G., Gliga, S., Fuchs, A., Orth, H.M., Schönfeld, A., Luedde, T. and Feldt, T. (2022) Prevalence of H. pylori among Asymptomatic HIV-Positive and Negative Individuals in Central Ethiopia and Efficacy of Eradication Therapy. IJID Regions, 2, 169-174. [Google Scholar] [CrossRef] [PubMed]
[44] Nkuize, M., Vanderpas, J., Buset, M., Delforge, M., Cadière, G.B. and De Wit, S. (2021) Failure to Eradicate Helicobacter pylori Infection Is More Frequent among HIV-Positive Patients. HIV Medicine, 22, 547-556. [Google Scholar] [CrossRef] [PubMed]
[45] Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J.P., Liou, J.M., Schulz, C., Gasbarrini, A., Hunt, R.H., Leja, M., O’Morain, C., Rugge, M., Suerbaum, S., Tilg, H., Sugano, K., El-Omar, E.M. and European Helicobacter and Microbiota Study Group (2022) Management of Helicobacter pylori Infection: the Maastricht VI/Florence Consensus Report. Gut, 71, 1724-1762. [Google Scholar] [CrossRef] [PubMed]
[46] 中华医学会消化病学分会幽门螺杆菌学组, 周丽雅. 2022中国幽门螺杆菌感染治疗指南[J]. 胃肠病学, 2022, 27(3): 150-162.
[47] Nkuize, M., Vanderpas, J., Buset, M., Gomez-Galdon, M., Delforge, M., Miendje-Deyi, V.Y., Muls, V. and De Wit, S. (2021) Primary Antibiotic Resistance of Helicobacter pylori Isolates Is Twofold More Frequent in HIV-Positive than HIV-Negative Individuals: A Descriptive Observational Study. Microbiology Open, 10, e1184. [Google Scholar] [CrossRef] [PubMed]
[48] Nkuize, M., De Wit, S., Muls, V., Delforge, M., Miendje Deyi, V.Y., Cadière, G.B. and Buset, M. (2015) HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. PLOS ONE, 10, e0145119. [Google Scholar] [CrossRef] [PubMed]

为你推荐